GeneQuine Biotherapeutics
Latest round
- Series A
Last raised
- Oct 2020
Total raised
- $6.4M
Investors
- 5
About GeneQuine Biotherapeutics
Based in Hamburg, Germany, and founded in 2012, GeneQuine Biotherapeutics GmbH develops gene therapy-based drugs for the treatment of musculoskeletal diseases. Osteoarthritis is a joint disorder in humans and animals such as dogs and horses. The company founded by Killian Guse, PhD, and Stanislav Plutlzkl, PhD. The company’s line of products; GQ2-201 is a gene therapy for the treatment of osteoarthritis in horses. GQ-202 a gene therapy treatment for osteoarthritis in dogs. While GQ-203 is a gene transfer vector for the treatment of osteoarthritis in humans. The company also provides GQ-301, GQ-302, and GQ-303 a gene therapy drugs for osteoarthritis of horses, dos, and humans. GeneQuine Biotherapeutics GmbH plans to expand the gene therapy vector platform and to grow the company’s operations. The company also plans to develop new gene therapy for the treatment of intervertebral disc degeneration.
Who invested in GeneQuine Biotherapeutics
5 investors across 3 rounds
See all investors in GeneQuine Biotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about GeneQuine Biotherapeutics
Who invested in GeneQuine Biotherapeutics?
GeneQuine Biotherapeutics has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GeneQuine Biotherapeutics raised?
GeneQuine Biotherapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did GeneQuine Biotherapeutics last raise money?
GeneQuine Biotherapeutics's most recent round on record is a Series A, in Oct 2020.
What does GeneQuine Biotherapeutics do?
Based in Hamburg, Germany, and founded in 2012, GeneQuine Biotherapeutics GmbH develops gene therapy-based drugs for the treatment of musculoskeletal diseases.
Where is GeneQuine Biotherapeutics headquartered?
GeneQuine Biotherapeutics is headquartered in Hamburg, Germany.
Which VCs invest in companies like GeneQuine Biotherapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at GeneQuine Biotherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like GeneQuine Biotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.